Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Thavendiranathan, P; Zhang, LL; Zafar, A; Drobni, ZD; Mahmood, SS; Cabral, M; Awadalla, M; Nohria, A; Zlotoff, DA; Thuny, F; Heinzerling, LM; Barac, A; Sullivan, RJ; Chen, CL; Gupta, D; Kirchberger, MC; Hartmann, SE; Weinsaft, JW; Gilman, HK; Rizvi, MA; Kovacina, B; Michel, C; Sahni, G; Gonzalez-Mansilla, A; Calles, A; Fernandez-Aviles, F; Mahmoudi, M; Reynolds, KL; Ganatra, S; Gavira, JJ; Gonzalez, NS; Castro, MGD; Kwong, RY; Jerosch-Herold, M; Coelho, OR; Afilalo, J; Zatarain-Nicolas, E; Baksi, AJ; Wintersperger, BJ; Calvillo-Arguelles, O; Ederhy, S; Yang, EH; Lyon, AR; Fradley, MG; Neilan, TG.

Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2021; 77(12): 1503-1516 Nº de citas: 163 [doi:10.1016/j.jacc.2021.01.050]

Martin, M; Ramos-Medina, R; Bernat, R; Garcia-Saenz, JA; del Monte-Millan, M; Alvarez, E; Cebollero, M; Moreno, F; Gonzalez-Haba, E; Bueno, O; Romero, P; Massarrah, T; Echavarria, I; Jerez, Y; Herrero, B; del Val, RG; Lobato, N; Rincon, P; Palomero, MI; Marquez-Rodas, I; Lizarraga, S; Asensio, F; Lopez-Tarruella, S.

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

Scientific Reports. 2021; 11(1): 7064-7064 Nº de citas: 25 [doi:10.1038/s41598-021-85962-4]

Rivera, F; Izquierdo-Manuel, M; Garcia-Alfonso, P; de Castro, EM; Gallego, J; Limon, ML; Alsina, M; Lopez, L; Galan, M; Falco, E; Manzano, JL; Gonzalez, E; Munoz-Unceta, N; Lopez, C; Aranda, E; Fernandez, E; Jorge, M; Jimenez-Fonseca, P.

Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial

EUROPEAN JOURNAL OF CANCER. 2021; 145: 158-167 Nº de citas: 58 [doi:10.1016/j.ejca.2020.12.005]

Mountzios, G; de Toma, A; Economopoulou, P; Friedlaender, A; Banini, M; Lo Russo, G; Baxevanos, P; Roila, F; Banna, GL; Christopoulou, A; Jimenez, B; Collazo-Lorduy, A; Linardou, H; Calles, A; Galetta, D; Addeo, A; Camerini, A; Pizzutilo, P; Kosmidis, P; Garassino, MC; Proto, C; Signorelli, D; Metro, G.

Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller

Clinical Lung Cancer. 2021; 22(2): 180-192 Nº de citas: 20 [doi:10.1016/j.cllc.2020.09.017]

Jimenez-Fonseca, P; Carmona-Bayonas, A; de Castro, EM; Custodio, A; Pijaume, CP; Hernandez, R; Aguado, G; Unanua, NC; Cano, JM; Lopez, F; Garrido, M; Montes, AF; Visa, L; Canovas, MS; Limon, ML; Lago, NM; Pimentel, P; Hurtado, A; Azkarate, A; Longo, F; Diez, M; Arias-Martinez, A; Sauri, T; Carnicero, AM; Mangas, M; Richard, MM; Granja, M; Ramchandani, A; Perez, CH; Cerda, P; Gil-Negrete, A; Calvo, M; Tocino, RV; Gallego, J.

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

Gastric Cancer. 2021; 24(2): 445-456 Nº de citas: 8 [doi:10.1007/s10120-020-01116-x]

Garcia-Alfonso, P; Diaz-Rubio, E; Abad, A; Carrato, A; Massuti, B; Ortiz-Morales, MJ; Mozo, JLM; Munoz, A; Duran, G; Sastre, J; Safont, MJ; Ferreiro, R; Rivera, F; Gonzalez, E; Valladares-Ayerbes, M; Gravalos, C; Alonso-Orduna, V; Vieitez, JM; Yubero, A; Aranda, E.

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

DRUGS & AGING. 2021; 38(3): 219-231 Nº de citas: 3 [doi:10.1007/s40266-021-00834-w]

Onesti, CE; Tagliamento, M; Curigliano, G; Harbeck, N; Bartsch, R; Wildiers, H; Tjan-Heijnen, V; Martin, M; Rottey, S; Generali, D; Campone, M; Cristofanilli, M; Pusztai, L; Peeters, M; Berchem, G; Cortes, J; Ruhstaller, T; Ciruelos, E; Rugo, HS; Jerusalem, G.

Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology

JCO Global Oncology. 2021; 7: 162-172 Nº de citas: 40 [doi:10.1200/GO.20.00589]

Mayer, EL; Dueck, AC; Martin, M; Rubovszky, G; Burstein, HJ; Bellet-Ezquerra, M; Miller, KD; Zdenkowski, N; Winer, EP; Pfeiler, G; Goetz, M; Ruiz-Borrego, M; Anderson, D; Nowecki, Z; Loibl, S; Moulder, S; Ring, A; Fitzal, F; Traina, T; Chan, A; Rugo, HS; Lemieux, J; Henao, F; Lyss, A; Novoa, SA; Wolff, AC; Vetter, M; Egle, D; Morris, PG; Mamounas, EP; Gil-Gil, MJ; Prat, A; Fohler, H; Metzger, O; Schwarz, M; DuFrane, C; Fumagalli, D; Theall, KP; Lu, DR; Bartlett, CH; Koehler, M; Fesl, C; DeMichele, A; Gnant, M.

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

LANCET ONCOLOGY. 2021; 22(2): 212-222 Nº de citas: 229 [doi:10.1016/S1470-2045(20)30642-2]

Martinez-Trufero, J; De Sande-Gonzalez, LM; Luna, P; Martin-Broto, J; Alvarez, R; Marquina, G; Diaz-Beveridge, R; Poveda, A; Cano, JM; Cruz-Jurado, J; Pousa, AL; Salgado, MAV; Valverde-Morales, CM; Sevilla, I; Martinez-Garcia, J; Rubio-Casadevall, J; De Juan, A; Carrasco, JA; Moura, DS; Gurruchaga-Sotes, I; Gutierrez, A.

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study

Cancers. 2021; 13(4): Nº de citas: 8 [doi:10.3390/cancers13040792]

Tabernero, J; Grothey, A; Van Cutsem, E; Yaeger, R; Wasan, H; Yoshino, T; Desai, J; Ciardiello, F; Loupakis, F; Hong, YS; Steeghs, N; Guren, TK; Arkenau, HT; Garcia-Alfonso, P; Elez, E; Gollerkeri, A; Maharry, K; Christy-Bittel, J; Kopetz, S.

Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

JOURNAL OF CLINICAL ONCOLOGY. 2021; 39(4): 273-284 Nº de citas: 436 [doi:10.1200/JCO.20.02088]

Loibl, S; Marme, F; Martin, M; Untch, M; Bonnefoi, H; Kim, SB; Bear, H; Mc Carthy, N; Olive, MM; Gelmon, K; Saenz, JG; Kelly, CM; Reimer, T; Toi, M; Rugo, HS; Seiler, S; Nekljudova, V; Denkert, C; Gnant, M; Makris, A; Burchardi, N; von Minckwitz, G.

Phase III Study of Palbociclib Combined With Endocrine Therapy in Patients With Hormone Receptor-Positive, HER2-Negative Primary Breast Cancer and With High Relapse Risk After Neoadjuvant Chemotherapy: First Results From PENELOPE-B

Clinical Advances in Hematology & Oncology. 2021; 19(2): 9-10

O'Shaughnessy, JA; Johnston, S; Harbeck, N; Toi, M; Im, YH; Reinisch, M; Shao, ZM; Lehtinen, PLK; Huang, CS; Tryakin, A; Goetz, M; Rugo, HS; Senkus, E; Testa, L; Andersson, M; Tamura, K; Steger, GG; Del Mastro, L; Cox, J; Forrester, T; Sherwood, S; Li, XL; Wei, R; Martin, M; Rastogi, P.

Primary Outcome Analysis of Invasive Disease-Free Survival for MonarchE: Abemaciclib Combined With Adjuvant Endocrine Therapy for High-Risk Early Breast Cancer

Clinical Advances in Hematology & Oncology. 2021; 19(2): 15-16

Chan, A; Moy, B; Mansi, J; Ejlertsen, B; Holmes, FA; Chia, S; Iwata, H; Gnant, M; Loibl, S; Barrios, CH; Somali, I; Smichkoska, S; Martinez, N; Alonso, MG; Link, JS; Mayer, IA; Cold, S; Murillo, SM; Senecal, F; Inoue, K; Ruiz-Borrego, M; Hui, RN; Denduluri, N; Patt, D; Rugo, HS; Johnston SRD; Bryce, R; Zhang, B; Xu, F; Wong, A; Martin, M; ExteNET Study Group.

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial

Clinical Breast Cancer. 2021; 21(1): 80 Nº de citas: 186 [doi:10.1016/j.clbc.2020.09.014]

Ruiz-Pinto, S; Pita, G; Martin, M; Nunez-Torres, R; Cuadrado, A; Shahbazi, MN; Caronia, D; Kojic, A; Moreno, LT; de la Torre-Montero, JC; Lozano, M; Lopez-Fernandez, LA; Ribelles, N; Garcia-Saenz, JA; Alba, E; Milne, RL; Losada, A; Perez-Moreno, M; Benitez, J; Gonzalez-Neira, A.

Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine-Induced Hand-Foot Syndrome

CLINICAL PHARMACOLOGY & THERAPEUTICS. 2021; 109(2): 462-470 Nº de citas: 7 [doi:10.1002/cpt.2013]

Laria, JC; Aguilera-Morillo, MC; Alvarez, E; Lillo, RE; Lopez-Taruella, S; del Monte-Millan, M; Picornell, AC; Martin, M; Romo, J.

Iterative Variable Selection for High-Dimensional Data: Prediction of Pathological Response in Triple-Negative Breast Cancer

Mathematics. 2021; 9(3): Nº de citas: 4 [doi:10.3390/math9030222]

Custodio-Cabello, S; Cabezon-Gutierrez, L; Palka-Kotlowska, M; Acebes, EO; Khosravi-Shahi, P.

Ant-EGFR Antibody Plus Chemotherapy Treatment in a Patient with Synchronous Merkel Cell Carcinoma and Colorectal Cancer

Cureus Journal of Medical Science. 2021; 13(1): [doi:10.7759/cureus.12916]

Schettini, F; Chic, N; Braso-Maristany, F; Pare, L; Pascual, T; Conte, B; Martinez-Saez, O; Adamo, B; Vidal, M; Barnadas, E; Fernandez-Martinez, A; Gonzalez-Farre, B; Sanfeliu, E; Cejalvo, JM; Perrone, G; Sabarese, G; Zalfa, F; Peg, V; Fasani, R; Villagrasa, P; Gavila, J; Barrios, CH; Lluch, A; Martin, M; Locci, M; De Placido, S; Prat, A.

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

npj Breast Cancer. 2021; 7(1): 1-1 Nº de citas: 532 [doi:10.1038/s41523-020-00208-2]

Gonzalez-Cao, M; Puertolas, T; Riveiro, M; Munoz-Couselo, E; Ortiz, C; Paredes, R; Podzamczer, D; Manzano, JL; Molto, J; Revollo, B; Carrera, C; Mateu, L; Fancelli, S; Espinosa, E; Clotet, B; Martinez-Picado, J; Cerezuela, P; Soria, A; Marquez, I; Mandala, M; Berrocal, A; Spanish Melanoma Grp GEM.

Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)

Journal for ImmunoTherapy of Cancer. 2021; 9(3): Nº de citas: 17 [doi:10.1136/jitc-2020-001664]